HDSA 2025: Support can help combat Huntington's disease stigma
At the HDSA 2025 convention, social workers reported that building community among Huntington's patients can help combat disease stigma.| Huntington's Disease News
At the HDSA 2025 convention, social workers reported that building community among Huntington's patients can help combat disease stigma.| Huntington's Disease News
The once-daily oral therapy Ingrezza, from Neurocrine, has now been approved in the U.S. to treat chorea in adults with Huntington’s disease.| Huntington's Disease News
Society wants us to act heroic, but that's not always possible, opines columnist Carlos Briceño, who recommends embracing vulnerability.| Huntington's Disease News
Mary Chapman is an award-winning journalist who writes feature stories for Huntington's Disease News. She covers the latest news and information on a variety of Huntington's disease topics.| Huntington's Disease News
Levels of GFAP in cerebrospinal fluid (CSF) may be a marker of Huntington’s disease progression, a study found.| Huntington's Disease News
